The only international event dedicated to discussing regulatory, ethical and operational aspects of running clinical trials in Russia

30 November - 1 December 2021

Moscow, Russia, Intercontinental Hotel

Speakers in 2021

Dmitriy Grinko, Director, Republican Clinical and Pharmacological Laboratory, Republican Unitary Enterprise
Dmitriy Grinko

Director

Republican Clinical and Pharmacological Laboratory, Republican Unitary Enterprise "Center for Examinations and Tests in Health Service"

Irina Efremova,  Head , Republican Clinical and Pharmacological Laboratory, Republican Unitary Enterprise
Irina Efremova

Head

Republican Clinical and Pharmacological Laboratory, Republican Unitary Enterprise "Center for Examinations and Tests in Health Service"

Dmitry Rozhdestvensky, Head, Division for Coordination of Common Market for Drugs and Medical Devices Formation, Eurasian Economic Commission
Dmitry Rozhdestvensky

Head, Division for Coordination of Common Market for Drugs and Medical Devices Formation

Eurasian Economic Commission

Elena Khvostikova, Director, “Genome” Patient Support Centre
Elena Khvostikova

Director

“Genome” Patient Support Centre

Anton Seleznev, Global Medical Director, Biocad
Anton Seleznev

Global Medical Director

Biocad

Alina Mustafina, Medical devices department lector, RMANPO
Alina Mustafina

Medical devices department lector

RMANPO

Maria Leer, Head of Medical Projects Group, Takeda
Maria Leer

Head of Medical Projects Group

Takeda

Almira Galeeva, Director of Clinical Research & Medical Affairs, AIPM Russia
Almira Galeeva

Director of Clinical Research & Medical Affairs

AIPM Russia

Olga Melnik, Head of Clinical Operations, Novartis Pharma
Olga Melnik

Head of Clinical Operations

Novartis Pharma

Vladimir Andrianov, Head of department of clinical trials, Sechenov University
Vladimir Andrianov

Head of department of clinical trials

Sechenov University

Artem Poltoratskiy, Head of the Department for Pre-Clinical and Clinical Trials, National Medical Research Centre of Oncology Named after N.N.Petrov
Artem Poltoratskiy

Head of the Department for Pre-Clinical and Clinical Trials

National Medical Research Centre of Oncology Named after N.N.Petrov

Igor Makarenko, Head of Medical Department, GEROPHARM
Igor Makarenko

Head of Medical Department

GEROPHARM

Alexey Kolbin, Head of Clinical Pharmacology Department, Pavlov First Saint Petersburg State Medical University
Alexey Kolbin

Head of Clinical Pharmacology Department

Pavlov First Saint Petersburg State Medical University

Evgeniya Novoderezhkina, RWE Manager Russia, RWE Lead (CEE), Novartis
Evgeniya Novoderezhkina

RWE Manager Russia, RWE Lead (CEE)

Novartis

Roman Serguchev, Сlinical trials Quality Assurance Manager, Drugs Technology
Roman Serguchev

Сlinical trials Quality Assurance Manager

Drugs Technology

Alexander Solodovnikov, Associate Director, Operations, Statandocs
Alexander Solodovnikov

Associate Director, Operations

Statandocs

Ekaterina Sorokina, Director, Statandocs
Ekaterina Sorokina

Director

Statandocs

Olga Filon, Medical Director, Drugs Technology
Olga Filon

Medical Director

Drugs Technology

Julia Trakhtenberg, Medical director, IPHARMA
Julia Trakhtenberg

Medical director

IPHARMA

Irina Borovova, President, Association of Oncology Patients “Zdravstvuy!”
Irina Borovova

President

Association of Oncology Patients “Zdravstvuy!”

Ivan Karnaukhov, Head of clinical research and experimental medicine department, Saint-Petersburg State University, Clinic of advanced medical technologies n. a. Nicolay I. Pirogov
Ivan Karnaukhov

Head of clinical research and experimental medicine department

Saint-Petersburg State University, Clinic of advanced medical technologies n. a. Nicolay I. Pirogov

Andrey Alasheev, Director, Sciencefiles
Andrey Alasheev

Director

Sciencefiles

Victoria Razjivina, Head of clinical trials department, Drugs Technology (R-Pharm group of companies)
Victoria Razjivina

Head of clinical trials department

Drugs Technology (R-Pharm group of companies)

Yan Vlasov, Co-Chair, Russian Patients Association
Yan Vlasov

Co-Chair

Russian Patients Association

Ksenia Teplova-Bareysha, Country Head of Site Management, Bayer
Ksenia Teplova-Bareysha

Country Head of Site Management

Bayer

Marina Sekacheva, Director, Institute for Personalized Medicine, Health Management Clinic, Sechenov University
Marina Sekacheva

Director, Institute for Personalized Medicine

Health Management Clinic, Sechenov University

Maria Litvinova, Registration Engineer Lead, Elamed
Maria Litvinova

Registration Engineer Lead

Elamed

Andrey Shutov, , Novartis
Andrey Shutov

Novartis

Natalia Gavrilova, Neurologist, CSO , Prof. Y Shoenfeld Center of Autoimmune Diseases and Post-COVID Syndrome
Natalia Gavrilova

Neurologist, CSO

Prof. Y Shoenfeld Center of Autoimmune Diseases and Post-COVID Syndrome

Lidia Soprun, Epidemologist, Center head of organisational and methodological work , Prof. Y Shoenfeld Center of Autoimmune Diseases and Post-COVID Syndrome
Lidia Soprun

Epidemologist, Center head of organisational and methodological work

Prof. Y Shoenfeld Center of Autoimmune Diseases and Post-COVID Syndrome

Alexander Khokhlov, Head of the Department of Clinical Pharmacology, Yaroslavl State Medical University
Alexander Khokhlov

Head of the Department of Clinical Pharmacology

Yaroslavl State Medical University

Elvira Mukhametshina, Medical Director, EAEU countries, R-Pharm
Elvira Mukhametshina

Medical Director, EAEU countries

R-Pharm

Francis Crawley, Executive Director, Good Clinical Practice Alliance - Europe (GCPA), Belgium
Francis Crawley

Executive Director

Good Clinical Practice Alliance - Europe (GCPA), Belgium

Mark Turner, Professor of Neonatology and Research Delivery, Institute of Life Course and Medical Sciences, University of Liverpool
Mark Turner

Professor of Neonatology and Research Delivery

Institute of Life Course and Medical Sciences, University of Liverpool

John Wise, Consultant and Programme Coordinator, Pistoia Alliance
John Wise

Consultant and Programme Coordinator

Pistoia Alliance

KEY TOPICS & FEATURES IN 2021:

o   The current status of the clinical trials market: what are the latest trends in Russia and globally?

o   Clinical trials during the Covid-19 pandemic: practical experiences, challenges and solutions found

o   Clinical trials in the Eurasian Union - registration practices and common rules in action

o   Acceleration of digitalisation in clinical trials: AI, remote monitoring, electronic registers, access to data and data safety

o   RWE - globally and in Russia: RWE as a key tool for the federal project “Digital technologies”

o   Live Interviews with sponsors and research & investigators centres

 

Why attend the Clinical Trials in Russia Forum 2021?

adamsmith 14october2018 049

Insights from 40+ experts: regulators, representatives of international and Russian pharmaceutical producers, CROs and investigators

adamsmith 13october2018 206

2-day information-rich programme that includes insightful presentations from leading sector players, interactive debates and round tables

adamsmith 13october2018 086

Unrivalled networking opportunities with 150+ attendees from such companies as AstraZeneca, Pfizer, Novartis, Bayer, Biocad, R-Pharm and many more

FEEDBACK FROM ATTENDEES

Unique opportunity for all the clinical trials sector players to meet and discuss the most burning issues.

Tatiana Minakova,

Associate Director, Clinical Monitoring, Syneos Health

The forum brings together representatives of all stakeholder groups involved in clinical trials – sponsors, CROs, regulators and investigators for a constructive dialogue aimed at improving all future processes.

Julia Semenova,

Pharma Development Unit Head, Novartis Russia

Very good overview of a large number of clinical trial topics and the specifics of the Russian market.

Henryette Schatt,

JDirector eCOA Business Development, ERT (Switzerland)

Very interesting insight into the latest developments in the Russian market.

Stefanie Rau,

Clinical Trials and Pharmacovigilance Manager Europe, MUCOS Pharma (Germany)


Sponsored by:

Supporting organisations & media